Fundraising Fox

Elephas Biosciences

Madison, US · Founded 2021 · Delaware corporation · 1 known investors

elephas.com ↗

Elephas develops elive, a live-tissue platform technology that predicts immunotherapy response in cancer patients by measuring real-time immune activity in intact tumor tissue. The company serves oncologists and patients to enable personalized cancer treatment selection.

BiotechDigital HealthHealthtechMedical Devicesin /elephasbiosciences

Founders & leadership

MB
Michelle B. AroraDirector
TP
Terrence P. BradyExecutive Officer
JO
Jonathan OlinerExecutive Officer
MK
Maneesh K. AroraExecutive Officer, Director, Promoter

Investors · 1

ARCH Venture PartnersChicago · $50K – $250M

Reported raises · per SEC filings

Form D private placements
▶$51.2MraisedJan 2024 · 10 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven GalsonDirector
  • Terrence BradyExecutive Officer
  • Andrea JacksonDirector
  • Maneesh K. AroraExecutive Officer, Director
  • Paul BernsDirector
Offering amount
$55M
Amount sold
$51.2M
First sale
Nov 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$41.5MraisedSep 2022 · 7 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrea JacksonDirector
  • Steven GalsonDirector
  • Maneesh K. AroraExecutive Officer, Director
  • Terrence P. BradyExecutive Officer
  • Paul BernsDirector
Offering amount
$43.5M
Amount sold
$41.5M
First sale
Aug 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedOct 2021 · 17 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Terrence P. BradyExecutive Officer
  • Maneesh K. AroraExecutive Officer, Director, Promoter
  • Michelle B. AroraDirector
  • Jonathan OlinerExecutive Officer
Offering amount
$1M
Amount sold
$1M
First sale
May 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20MraisedOct 2021 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michelle B. AroraDirector
  • Terrence P. BradyExecutive Officer
  • Jonathan OlinerExecutive Officer
  • Maneesh K. AroraExecutive Officer, Director, Promoter
Offering amount
$20M
Amount sold
$20M
First sale
Sep 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news